Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

Brand Names not allowed on formulary.
July 23, 2019

The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary. Click here for more information on the formulary. Continue reading


Human Trafficking
July 10, 2019

Click here for new profession requirements and reporting procedures regarding Human Trafficking Continue reading